News Archive
11 December 2009
Trading Update
Eden Research plc (PLUSMARKETS: EDE), a leading UK agrochemical development company, today announces a trading update for the quarter ended 30th September 2009. Eden's strategy is focused on the development and commercialisation of terpene-based technology for agricultural use.
Business Highlights
- Highly successful trial data announced for Spider Mites, Whitefly and Nematode products indicating strong prospects for commercialisation of future products
- Final submission of 3AEY to the Chemicals Regulation Directorate completed
Financial Highlights
- Loss for the period of £251,779 , in line with the Company's expectations
- Revenue for the period of £17,265, being upfront payments for the Lachlan agreement
- Administrative expenses £97,637, reflecting the on-going low cost base of the Company
Clive Newitt, Managing Director said:
"Further to our interim results announced in September, we are progressing well with various current and potential licensing agreements and look forward to making announcements shortly."
The directors of Eden Research plc are responsible for the content of this announcement
Enquiries:
Eden Research plc
Clive Newitt, Managing Director
01993 862761
St Helens Capital Partners LLP
Mark Anwyl or Duncan Vasey
020 7368 6959